Movatterモバイル変換


[0]ホーム

URL:


Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Nature Medicine
  • Article
  • Published:

Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients

Nature Medicinevolume 5pages423–426 (1999)Cite this article

Abstract

Ebola virus is very pathogenic in humans. It induces an acute hemorrhagic fever that leads to death in about 70% of patients1. We compared the immune responses of patients who died from Ebola virus disease with those who survived during two large outbreaks in 1996 in Gabon. In survivors, early and increasing levels of IgG, directed mainly against the nucleoprotein and the 40-kDa viral protein, were followed by clearance of circulating viral antigen and activation of cytotoxic T cells, which was indicated by the upregulation of FasL, perforin, CD28 and gamma interferon mRNA in peripheral blood mononuclear cells. In contrast, fatal infection was characterized by impaired humoral responses, with absent specific IgG and barely detectable IgM. Early activation of T cells, indicated by mRNA patterns in peripheral blood mononuclear cells and considerable release of gamma interferon in plasma, was followed in the days preceding death by the disappearance of T cell-related mRNA (including CD3 and CD8). DNA fragmentation in blood leukocytes and release of 41/7 nuclear matrix protein in plasma indicated that massive intravascular apoptosis proceeded relentlessly during the last 5 days of life. Thus, events very early in Ebola virus infection determine the control of viral replication and recovery or catastrophic illness and death.

This is a preview of subscription content,access via your institution

Access options

Access through your institution

Subscription info for Japanese customers

We have a dedicated website for our Japanese customers. Please go tonatureasia.com to subscribe to this journal.

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Circulating Ebola antigen levels and humoral responses in Ebola-infected patients.
Figure 2: Analysis of T-cell responses in Ebola-infected patients.
Figure 3: Detection of apoptosis in fatalities.

Similar content being viewed by others

References

  1. Peters, C.J. & Khan, A.S. inCurrent Topics in Microbiology and Immunology Vol. 235 (ed. Klenk, H.-D.) 85– 95 (Springer-Verlag, Berlin, 1999).

    Google Scholar 

  2. Ksiazek, T.G. et al. Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates.J. Clin. Microbiol.30, 947–950 (1992).

    CAS PubMed PubMed Central  Google Scholar 

  3. Xu, L. et al. Immunization for Ebola virus infection.Nature Med.4, 37–42 (1998 ).

    Article CAS PubMed  Google Scholar 

  4. Clark, E.A. & Ledbetter, J.A. How B and T cells talk to each other.Nature367, 425– 428 (1994).

    Article CAS PubMed  Google Scholar 

  5. Lowin, B., Hahne, M., Mattmann, C. & Tschopp, J. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature370, 650–653 ( 1994).

    Article CAS PubMed  Google Scholar 

  6. Kayagaki, N. et al. Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med.182, 1777–1783 (1995).

    Article CAS PubMed  Google Scholar 

  7. Kiener, P.A. et al. Human monocytic cells contain high levels of intracellular Fas ligand. Rapid release following cellular activation.J. Immunol.159, 1594–1598 ( 1997).

    CAS PubMed  Google Scholar 

  8. Feldmann, H. et al. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages.J. Virol.70, 2208 –2214 (1996).

    CAS PubMed PubMed Central  Google Scholar 

  9. Kroemer, G. The proto-oncogen Bcl-2 and its role in regulating apoptosis. Nature Med.3, 614–620 ( 1997).

    Article CAS PubMed  Google Scholar 

  10. Miller, T., Beausang, L.A., Meneghini, M. & Lidgard, G. Death-induced changes to the nuclear matrix: the use of anti-nuclear matrix antibodies to study agents of apoptosis.Biotechniques 15, 1042–1047 (1993).

    CAS PubMed  Google Scholar 

  11. Jeon, S.H. et al. Expression ofTcf-1 mRNA and surface TCR-CD3 complexes are reduced during apoptosis of T cells.Int. Immunol. 10, 1519–1527 (1998).

    Article CAS PubMed  Google Scholar 

  12. Fisher-Hoch, S.P. et al. Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola).J. Inf. Dis.152, 887–894 (1985).

    Article CAS  Google Scholar 

  13. Baskerville, A., Bowen, E.T., Platt, G.S., McArdell, L.B. & Simpson, D.I. The pathology of experimental Ebola virus infection in monkeys.J. Pathol.125, 131– 138 (1978).

    Article CAS PubMed  Google Scholar 

  14. Baskerville, A., Fisher-Hoch, S.P., Neild, G.H. & Dowsett, A.B. Ultrastructural pathology of experimental Ebola haemorrhagic fever virus infection.J. Pathol.147, 199–209 (1985).

    Article CAS PubMed  Google Scholar 

  15. Jaax, N.K. et al. Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch. Pathol. Lab. Med.120, 140–155 (1996).

    CAS PubMed  Google Scholar 

  16. Johnson, E., Jaax, N., White, J. & Jahrling, P. Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus.Int. J. Exp. Pathol.76, 227–236 (1995).

    CAS PubMed PubMed Central  Google Scholar 

  17. Yang, Z.-Y. et al. Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins.Science.279, 1034–1037 (1998).

    Article CAS PubMed  Google Scholar 

  18. Zaki, S.R., Greer, P.W., Goldsmith, C.S. & Coffield, L.M. in International Colloquium on Ebola Virus Research (Institute of Tropical Medicine, Antwerp, Belgium, 1996).

    Google Scholar 

  19. Gallimore, A. et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes.J. Exp. Med. 1383–1393 (1998 ).

  20. Suda, T., Hashimoto, H., Tanaka, M., Ochi, T. & Nagata, S. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J. Exp. Med.186, 2045–2050 (1997).

    Article CAS PubMed PubMed Central  Google Scholar 

  21. Tanaka, M., Itai, T., Adachi, M. & Nagata, S. Downregulation of Fas ligand by shedding.Nature Med.4, 31–36 (1998).

    Article CAS PubMed  Google Scholar 

  22. Georges-Courbot, M.C. et al. Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Emerg. Infect. Dis.3, 59–62 (1997).

    Article CAS PubMed PubMed Central  Google Scholar 

  23. WHO. Recommendations for management of viral haemorrhagic fevers in Africa, inWorkshop on Viral Haemorrhagic Fevers (Sierra Leone, 1985).

  24. Feldmann, H., Nichol, S.T., Schikore, M., Slenczka, W. & Klenk, H.-D. Glycosylation and oligomerization of the spike protein of Marburg virus.Virology182, 353–356 (1991).

    Article CAS PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to C. Tevi-Benissan and P. Tshipamba for their assistance on fieldwork, and A. Pendy, B. Pambo and P. Obiang for access to patient specimens. We also thank V.E. Volchkov, P.E. Rollin and T.G. Ksiazek for providing Ebola-specific reagents and for their assistance with western blot analysis and IgM detection. S.B. is supported by a grant from the Ministère de la Recherche et de l'Enseignement Supérieur (France). CIRMF is supported by the state of Gabon, ELF-Gabon and the Ministère de la Coopération Française.

Author information

Author notes
  1. S.B. and E.M.L. contributed equally to this work

Authors and Affiliations

  1. Centre International de Recherches Médicales de Franceville, B.P. 769, Franceville, Gabon

    Sylvain Baize, Eric M. Leroy, M.-C. Georges-Courbot, Joseph Lansoud-Soukate & Alain J. Georges

  2. Centre d'Immunologie et de Biologie Parasitaire, INSERM U 167, Institut Pasteur de Lille, 1 rue du Professeur Calmette , Lille, 59019, France

    Sylvain Baize & Monique Capron

  3. Laboratoire Central d'Immunologie Cellulaire et Tissulaire, CNRS U 625, hôpital de la Pitié-Salpétrière, Paris,, France

    Patrice Debré

  4. Fondation Marcel Mérieux, 17 rue Bourgelat, Lyon, 69002, France

    Susan P. Fisher-Hoch

  5. Pasteur/Mérieux/Connaught, 1541 avenue Marcel Mérieux, Marcy l'Etoile , 69260, France

    Joseph B. McCormick

Authors
  1. Sylvain Baize

    You can also search for this author inPubMed Google Scholar

  2. Eric M. Leroy

    You can also search for this author inPubMed Google Scholar

  3. M.-C. Georges-Courbot

    You can also search for this author inPubMed Google Scholar

  4. Monique Capron

    You can also search for this author inPubMed Google Scholar

  5. Joseph Lansoud-Soukate

    You can also search for this author inPubMed Google Scholar

  6. Patrice Debré

    You can also search for this author inPubMed Google Scholar

  7. Susan P. Fisher-Hoch

    You can also search for this author inPubMed Google Scholar

  8. Joseph B. McCormick

    You can also search for this author inPubMed Google Scholar

  9. Alain J. Georges

    You can also search for this author inPubMed Google Scholar

Corresponding authors

Correspondence toSylvain Baize orEric M. Leroy.

Rights and permissions

About this article

Cite this article

Baize, S., Leroy, E., Georges-Courbot, MC.et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients.Nat Med5, 423–426 (1999). https://doi.org/10.1038/7422

Download citation

Access through your institution
Buy or subscribe

Associated content

Surviving Ebola virus infection

  • Gary J. Nabel
Nature MedicineNews & Views

Advertisement

Search

Advanced search

Quick links

Nature Briefing

Sign up for theNature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox.Sign up for Nature Briefing

[8]ページ先頭

©2009-2025 Movatter.jp